Robert H. Carter | |
---|---|
Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases | |
Acting | |
In office December 2018 –February 2021 | |
Preceded by | Stephen I. Katz |
Succeeded by | Lindsey A. Criswell |
Personal details | |
Alma mater | Williams College Harvard Medical School |
Occupation | Rheumatologist,physician-scientist |
Robert H. Carter is an American rheumatologist and physician-scientist serving as the deputy director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) since 2008. He was the acting director of NIAMS from December 2018 until February 2021.
In 1978,Carter completed a bachelor’s degree in biology from Williams College, magna cum laude . [1] He received his M.D. from the Harvard Medical School in 1982. [1] He trained in internal medicine at the University of Virginia Health Sciences Center. [1] He was a fellow in rheumatology and immunology at Brigham and Women’s Hospital,and in molecular and clinical rheumatology at the Johns Hopkins School of Medicine. He is board certified in internal medicine and rheumatology. [1]
Carter was professor of medicine at the University of Alabama at Birmingham (UAB) and served as director of the division of clinical immunology and rheumatology. [1] He was the principal investigator (PI) of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)-supported UAB Rheumatic Disease Core Center and the PI of an Autoimmunity Center of Excellence supported by the National Institute of Allergy and Infectious Disease (NIAID). [1] He also served as staff physician at the Birmingham Veterans Affairs Medical Center. [2]
Carter became deputy director of NIAMS in 2008. [1] He leads the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus,a public-private partnership between government,industry,advocacy organizations and academic centers focused on tissues with active disease from patients. [2] Carter led the development of the back pain consortium as part of National Institutes of Health's Helping to End Addiction Long-term®(HEAL) Initiative. [2] Following the death of NIAMS director Stephen I. Katz,Carter was named acting director in December 2018. [2] He served in that role until rheumatologist Lindsey A. Criswell succeeded him in February 2021. [1]
Arthritis is a term often used to mean any disorder that affects joints. Symptoms generally include joint pain and stiffness. Other symptoms may include redness,warmth,swelling,and decreased range of motion of the affected joints. In some types of arthritis,other organs are also affected. Onset can be gradual or sudden.
Rheumatology is a branch of medicine devoted to the diagnosis and management of disorders whose common feature is inflammation in the bones,muscles,joints,and internal organs. Rheumatology covers more than 100 different complex diseases,collectively known as rheumatic diseases,which includes many forms of arthritis as well as lupus and Sjögren's syndrome. Doctors who have undergone formal training in rheumatology are called rheumatologists.
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is one of the institutes and centers that make up the National Institutes of Health,an agency of the United States Department of Health and Human Services (HHS).
J(arvis) Edwin Seegmiller,or Jay Seegmiller,was an American physician and biochemical geneticist best known for his role in discovering the biochemical basis of the Lesch–Nyhan syndrome. He was a rheumatologist and a pioneer in research on arthritic diseases and on aging.
Childhood arthritis is an umbrella term used to describe any rheumatic disease or chronic arthritis-related condition which affects individuals under the age of 16. There are several subtypes that differentiate themselves via prognosis,complications,and treatments. Most types are autoimmune disorders,where an individual's immune system may attack its own healthy tissues and cells.
Betty Diamond is an American physician and researcher. She is director of the Institute of Molecular Medicine at Northwell Health's Feinstein Institute for Medical Research in Manhasset,NY. She was elected a member of the National Academy of Sciences in 2022.
Michael D. Lockshin is an American professor and medical researcher. He is known for his work as a researcher of autoimmune diseases,with focus on antiphospholipid syndrome and lupus. He is Professor Emeritus of Medicine and the Director Emeritus of the Barbara Volcker Center for Women and Rheumatic Disease at Hospital for Special Surgery. He retired from HSS on January 31,2023.
John J. O'Shea is an American physician and immunologist.
Matthew H. Liang is a physician specializing in general internal medicine and rheumatology,Professor of Medicine at Harvard Medical School,Professor of Health Policy and Management at Harvard School of Public Health,and the Director Emeritus of Special Projects of the Robert B. Brigham Arthritis and Musculoskeletal Diseases Clinical Research Center which he founded. He is a founding faculty of the Division of General Internal Medicine and Primary Care at the Brigham and Women's Hospital and a founding faculty of the Clinical Effectiveness Program at the Harvard School of Public Health and is a Study Director in the Veterans Administration Cooperative Studies Program.
Ephraim Engleman was an American rheumatologist and a Clinical Professor of Medicine at the University of California,San Francisco. He had a major national and international impact on rheumatology during more than six decades,and wrote more than one hundred scientific and medical papers.
Terri H. Finkel is an American pediatric rheumatologist and immunologist who is the Children's Foundation of Memphis Endowed Chair and tenured professor of pediatrics at the University of Tennessee Health Science Center and St. Jude Children's Research Hospital. Previously,she was the pediatrician-in-chief,chair of pediatrics and chief scientific officer at Nemours Children's Hospital. She is known for her research into autoimmunity,AIDS,juvenile rheumatoid arthritis,lupus,and cancer. Her work has been recognized in more than 200 publications,10 U.S. patents,and 4 licensed technologies. Finkel has been placed in the top one percent of American pediatric rheumatologists by U.S. News &World Report. Her numerous honors include being named among America's Top Doctors by Castle Connolly every year since 2011 and induction into the Colorado Women's Hall of Fame in 1996.
Amita Aggarwal is an Indian clinical immunologist,rheumatologist and a Professor and Head at the Department of Clinical Immunology and Rheumatology of the Sanjay Gandhi Postgraduate Institute of Medical Sciences,Lucknow. Known for her studies in autoimmune rheumatic diseases,Aggarwal is a recipient of the Shakuntala Amir Chand Award of the Indian Council of Medical Research and an elected fellow of the National Academy of Sciences,India,National Academy of Medical Sciences and the National Academy of Medical Sciences. The Department of Biotechnology of the Government of India awarded her the National Bioscience Award for Career Development,one of the highest Indian science awards,for her contributions to biosciences in 2004.
Gary S. Firestein is an American rheumatologist,professor,and founding director of the Altman Clinical and Translational Research Institute (ACTRI) at the University of California San Diego and Senior Associate Vice Chancellor for Health Sciences at University of California,San Diego.
Nancy E. Lane is an American rheumatologist. She is an Endowed Professor of Medicine,Rheumatology,and Aging Research at the University of California,Davis and director of the UC Davis Musculoskeletal Diseases of Aging Research Group. She has also sat on the editorial boards of Nature Reviews Rheumatology,Rheumatology,Seminars in Arthritis and Rheumatism,Arthritis &Rheumatology, and The Journal of Rheumatology. Her work on aging and glucocorticoids in cell populations is internationally recognized.
Lindsey A. Criswell is an American rheumatologist and physician-scientist. She is director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Criswell was vice chancellor of research at University of California,San Francisco where she held the Jean S. Engleman Distinguished Professorship in Rheumatology.
Stephen Ira Katz was an American immunodermatologist who served as the director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases from 1995 to 2018. He was the Marion B. Sulzberger Professor of Dermatology at the Uniformed Services University of the Health Sciences from 1989 to 1995.
Mariana J. Kaplan is a rheumatologist and physician-scientist. She researches mechanisms of immune dysregulation,organ damage,and premature vascular disease in systemic autoimmunity. Kaplan is chief of the systemic autoimmunity branch at the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
India NAP Gail Houston Cassell is an American microbiologist whose research focuses on Mycoplasma species and multidrug-resistant tuberculosis. She is vice president of TB drug development at the Infectious Disease Research Institute. In 1994 she was the president of the American Society for Microbiology (ASM).
Paul Emery is a British rheumatologist,researcher,and academic. Emery has been the Versus Arthritis Professor of Rheumatology at the University of Leeds from 1995 to 2017,Head of its Rheumatology Department from 1995 to 2008. He is Head of the Academic Unit of Musculoskeletal Disease and Lead Clinician of Rheumatology at the Leeds Teaching Hospital NHS Trust,and was the Director of the NIHR Leeds Biomedical Research Centre from 2009 to 2022. He is known for introducing early intervention in inflammatory arthritis. Emery played a critical role in bringing sensitive imaging (MRI) into rheumatology practice. In 2012,Emery was awarded the Carol Nachman Prize for Rheumatology,and as of 2024,he has published over 1660 peer-reviewed articles with over 160,000 citations. Emery was the most cited European/World Rheumatologist in 2010-2020,and was selected in the European Journal of Clinical Investigation's "list of highly influential biomedical researchers,1996–2020."
Lynette (Lyn) March AM is an Australian rheumatologist and clinical epidemiologist. She is Liggins Professor of Rheumatology and Musculoskeletal Epidemiology in the Faculty of Medicine and Health at the University of Sydney,Australia.